JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CALLENDER, S. T.
Right arrow Articles by POWELL, J. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by CALLENDER, S. T.
Right arrow Articles by POWELL, J. F.
Journal of Pharmacology And Experimental Therapeutics, Vol. 82, Issue 3, 324-329, 1944
Copyright © 1944 by American Society for Pharmacology and Experimental Therapeutics


N1-DIMETHYLACROYL SULPHANILAMIDE (IRGAMID)

S. T. CALLENDER M.B., CH.B.1 and J. F. POWELL B.Sc.1

1 Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford

1. The concentration of N1-dimethylacroyl sulphanilamide (irgamid) in the blood and cerebro-spinal fluid and the excretion in the urine have been studied after various methods of administration.

2. High blood concentrations can be easily reached and maintained, and with smaller doses than are required with sulphapyridine or sulphanilamide.

3. The toxic effects in the cases studied were practically negligible—this may be correlated with the relatively small degree of acetylation. The drug is readily absorbed and well tolerated by the intramuscular route.

4. There is reason to believe, however, that the therapeutic efficiency is not high.

Submitted on August 29, 1944







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1944 by the American Society for Pharmacology and Experimental Therapeutics.